Orphazyme: H2 19 outlook
Research Note
2019-09-03
08:45
Last week, Orphazyme announced the results for their first half a year. The arimoclomol asset has made progress during 2019, and important milestones approach.
AH
Anders Hedlund
Disclosures and disclaimers